The Sampson lab uses computational genomics, bioinformatics and genetic epidemiology to discover novel NS-associated variants and characterize the clinical implications for patients harboring them. We also seek to understand the prevalence, clinical correlates, and molecular mechanisms underlying known genetic forms of NS. 



Recent News

  • "Nephrotic syndrome genomic discovery in era of Big Data" presentation posted Check our "Selected Publications" page for a modified version of our talk from the 2016 ASN Annual Meeting.
    Posted Nov 17, 2016, 2:47 PM by Matthew Sampson
  • Nephrotic Variant Server (NephVS) Beta 0.01 released We are excited to announce the release of NephVS, the Nephrotic Variant Server. The goal NephVS is to create a database composed of aggregated short-read sequencing and array-based ...
    Posted Nov 14, 2016, 12:32 PM by Matthew Sampson
  • tarSVM paper published Congrats to Chris Gillies for leading this study, in which we designed a novel method, tarSVM, to more accurately identify variants emerging from amplicon sequencing pipelines.  Had a great time ...
    Posted Jul 19, 2016, 5:27 AM by Matthew Sampson
  • Pediatric APOL paper published Our paper describing the prevalence and clinical correlates of APOL1-related glomerular disease in 104 black children was published online today at "Nephrology Dialysis Transplantation". This was a wonderful collaboration ...
    Posted Apr 27, 2016, 7:25 AM by Matthew Sampson
  • Congrats to Cassie! Cassie just finished her whirlwind tour across the Southeast for PhD interviews. Happily, she was quickly accepted at all 4 programs to which she applied :) Congrats to her. We look ...
    Posted Feb 25, 2016, 6:16 AM by Matthew Sampson
Showing posts 1 - 5 of 8. View more »